Literature DB >> 21905159

Oral contraceptive use in women at increased risk of breast/ovarian cancer: knowledge and attitudes.

Kim Tam Bui1, Claire E Wakefield, Nadine A Kasparian, Janet Tyler, Jason Abbott, Kathy Tucker.   

Abstract

BACKGROUND: Several of the health benefits and risks associated with the combined oral contraceptive pill (COCP) are particularly relevant to women at risk of hereditary breast and/or ovarian cancer.
METHODS: Eighty-three past female patients of an Australian hereditary cancer clinic aged 18-50 years completed a self-report questionnaire to assess their contraceptive practices, knowledge and information needs (44% response rate).
RESULTS: Ninety-two percent of participants had previously used the COCP, with a mean knowledge score of 3.63 out of 8. Nearly 40% reported that their family history of cancer was one reason they discontinued/avoided using the COCP. Women reported receiving insufficient COCP information and preferred a targeted information leaflet to answer their questions.
CONCLUSIONS: Although recall bias may have affected some women, there is a clear need to improve the consistency of information delivered to women at risk of hereditary breast and/or ovarian cancer, to ensure informed contraceptive choices are made.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21905159     DOI: 10.1002/pon.2049

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  3 in total

1.  The Impact of Hormonal Contraceptives on Breast Cancer Pathology.

Authors:  Jesse A Dorchak; Sifat Maria; Joseph L Guarinoni; Anette Duensing; Stella Somiari; Jane Cavanaugh; Brenda Deyarmin; Hai Hu; Joji Iida; Craig D Shriver; Paula A Witt-Enderby
Journal:  Horm Cancer       Date:  2018-04-23       Impact factor: 3.869

Review 2.  Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management.

Authors:  Anna L Beavis; Anna Jo Bodurtha Smith; Amanda Nickles Fader
Journal:  Int J Womens Health       Date:  2016-05-23

3.  BRCA mutation carriers' perceptions on postmenopausal hormone therapy: An Italian study.

Authors:  Giovanni Grandi; Valentina Boggio Sola; Laura Cortesi; Angela Toss; Giulia Andrea Giuliani; Maria Chiara Del Savio; Fabio Facchinetti
Journal:  Psychooncology       Date:  2021-05-28       Impact factor: 3.894

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.